PRDM5 and esophageal squamous cell carcinoma: However, postoperative adjuvant treatment for patients with stage I-II Esophageal squamous cell carcinoma after surgery has little benefit on OS, the results also suggested that postoperative adjuvant treatment for patients with high expression of PRDM5 can help to prolong DFS and OS.